| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 14,277 | 17,589 | ||
| Prepaid expenses and other current assets | 369 | 726 | ||
| Total current assets | 14,646 | 18,315 | ||
| Property and equipment, net | 22 | 27 | ||
| Right-of-use asset | 76 | 96 | ||
| Other assets | 21 | 21 | ||
| Total assets | 14,765 | 18,459 | ||
| Accounts payable | 2,599 | 2,875 | ||
| Clinical trial accrued liabilities | 1,562 | 1,463 | ||
| Accrued expenses and other current liabilities | 711 | 610 | ||
| Warrant liabilities | 167 | 114 | ||
| Related party payable | 3,316 | 3,675 | ||
| Lease liability, short-term | 79 | 83 | ||
| Total current liabilities | 8,434 | 8,820 | ||
| Lease liability, long-term | - | 15 | ||
| Total liabilities | 8,434 | 8,835 | ||
| Common stock, 0.001 par value per share, 100,000 shares authorized as of september 30, 2025 and december 31, 2024 24,215 and 8,637 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 24 | 24 | ||
| Additional paid-in capital | 153,207 | 153,123 | ||
| Accumulated deficit | -146,900 | -143,523 | ||
| Total stockholders' equity | 6,331 | 9,624 | ||
| Total liabilities and stockholders' equity | 14,765 | 18,459 | ||
MetaVia Inc. (MTVA)
MetaVia Inc. (MTVA)